Patents Represented by Attorney, Agent or Law Firm Gregory J. Hartwig
  • Patent number: 6528520
    Abstract: The invention provides an improved method of treating a human suffering from one or more conditions included within the Coronary Heart Disease Risk Factor (CHDRF) syndrome. The method includes administering, by a pharmaceutically effective mode, a drug composition having an opioidergic agent including an opiate antagonist, opiate having &mgr;-agonist activity or combination thereof, and an insulin secretagogue.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: March 4, 2003
    Assignee: CPD, LLC
    Inventor: Anton H. Clemens